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Abstract: Inflammation contributes to the development of fibrotic and malignant diseases. 
We assessed the ability of inflammatory cytokines to modulate endothelial cell survival and 
functions related to tissue repair/remodeling. Treatment with interleukin (IL)-1β or tumor 
necrosis factor (TNF)-α (2 ng/mL) led to human pulmonary artery endothelial cells becoming 
spindle-shaped fibroblast-like cells. However, immunoblot and DNA microarray showed no 
change in most endothelial and mesenchymal markers. In the presence of IL-1β or TNF-α, 
cells were resistant to apoptosis induced by deprivation of serum and growth factor, and were 
more migratory. In addition, cells treated with IL-1β or TNF-α contracted collagen gels more 
robustly. In contrast, transforming growth factor-β1 did not induce these responses. RNA 
interference targeting nuclear factor (NF)-κB p65 blocked the effects of IL-1β or TNF-α on cell 
morphologic change, survival, migration, and collagen gel contraction. These results suggest 
that endothelial cells may contribute to tissue repair/remodeling via the NF-κB signaling in a 
milieu of airway inflammation.
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Introduction
Airway inflammation is believed to play an important role in the development of many 
diseases. Endothelial cells are essential in normal development and   angiogenesis and 
also play an important role in inflammatory responses. In this regard,   upregulation 
of adhesion molecules on endothelial cells causes leukocytes to attach to the endothelium 
at sites of injuries and infection.1 The inflammatory cytokines interleukin (IL)-1β and 
tumor necrosis factor (TNF)-α are key players that regulate endothelial cell responses 
following inflammation.1 These cytokines can also contribute to development of tissue 
remodeling and fibrosis by modulating endothelial cell functions as demonstrated in 
dermal microvascular endothelial cells.2 These tissue repair/remodeling functions are 
akin to those of fibroblasts or myofibroblasts.
Cell migration and contraction of extracellular matrix are often used as in vitro mod-
els of tissue repair/remodeling. It is known that transforming growth factor (TGF)-β1 
stimulates fibroblast-mediated collagen gel contraction3 and   chemotaxis.4 On the other 
hand, IL-1β and TNF-α inhibit fibroblast-mediated collagen gel   contraction through the 
induction of nitric oxide and PGE2,5 both of which also inhibit chemotaxis.6,7 However, 
the effect of TGF-β1, IL-1β, or TNF-α on pulmonary endothelial cell-mediated tissue 
repair has not been studied.
Nuclear factor (NF)-κB is a transcription factor that mediates downstream 
  signaling of IL-1β and TNF-α and has major roles in inflammation, cell proliferation, Journal of Inflammation Research 2011:4 submit your manuscript | www.dovepress.com
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  differentiation, apoptosis, and cell survival.1,8,9 NF-κB is also 
involved in several critical functions of endothelial cells such 
as angiogenesis.10 However, the role of NF-κB in regulating 
tissue repair functions mediated by endothelial cells has not 
been reported.
The current study was, therefore, designed to investigate 
the effect of inflammatory cytokines (IL-1β and TNF-α) 
and TGF-β1 on human pulmonary artery endothelial cell 
(HPAEC) mediated tissue repair and remodeling. In addition, 
we assessed the role of NF-κB in modulating alteration of cell 
morphology, survival, and tissue repair functions in response 
to stimulation by IL-1β and TNF-α.
Materials and methods
Reagents
Recombinant human IL-1β, TNF-α, and TGF-β1 were 
purchased from R&D systems (Minneapolis, MN). FITC-
phalloidin and curcumin were purchased from Sigma-
Aldrich (St. Louis, MO). HRP-conjugated anti-rabbit IgG 
antibody was purchased from Rockland (Gilbertsville, 
PA). The small interference RNA (siRNA) targeting p65 
and   nontargeting control siRNA were purchased from 
Dharmacon (Lafayette, CO; siGENOME SMARTpool, 
M-003533-02 and D-001206-13, respectively).
cell culture and treatment
HPAEC were purchased from Clonetics, Lonza (Walkersville, 
MD), and maintained in endothelial cell growth medium 
(EGM-2, Lonza) which contains serum and growth   factors. 
Cells were treated with IL-1β (2 ng/mL), TNF-α (2 ng/mL), 
or TGF-β1 (2 ng/mL) in a 1:1 mixture EGM-2 to endothelial 
cell basal medium (EBM-2, which contains no serum or 
growth factors) resulting in a final concentration of 1% 
fetal bovine serum (FBS) (named as 1:1 EBM) for 2 days. 
  Concentrations of the cytokines were chosen based on pre-
liminary studies conducted from 1 to 5 ng/mL. To induce 
apoptosis, cells were incubated in EBM-2, which is without 
any growth factors or serum, for 5 days. In some experiments, 
cells were pretreated with curcumin (10 µM), a potent NF-κB 
inhibitor, for 1 hour prior to addition of cytokines. The A549 
alveolar epithelial-like cell line and HFL-1 human fetal lung 
fibroblasts were purchased from ATTC and maintained in 
DMEM with 10% FBS. A549 cells were treated with 2 ng/mL 
of TGF-β1 in DMEM with 0.5% FBS for 2 days.
cell length measurement
Cells were then fixed and stained with PROTOCOL 
HEMA3 solutions (Fisher Scientific Company L.L.C., 
Kalamazoo, MI). A Nikon Eclipse TE300 microscope (Nikon, 
Tokyo, Japan) equipped with a DP71 digital camera and DP 
Controller software (Olympus, Tokyo, Japan) was used to take 
photomicrographs. To quantify cell morphologic change, cell 
length was measured using the ImageJ 1.33u software, NIH. 
A mean of 50 cells for each condition was measured. Data are 
presented as percent compared with mean of control.
Visualization of F-actin
After treatment with cytokines, cells were fixed with 3.7% 
formaldehyde and permeabilized with 0.5% Triton X-100 in 
PBS for 15 minutes. After washing with PBS, cells were 
blocked with 5% bovine serum albumin for 1 hour, and 
then incubated with FITC-phalloidin (1 µg/mL) at room 
temperature for 1 hour.
Rna preparation and Dna microarray
After cells were treated with cytokines (2 ng/mL) for 2 days, 
total RNA was isolated by TRIzol (Invitrogen, Carlsbad, CA, 
USA) according to the manufacture’s protocol, and the total 
amount was quantified spectrophometrically (Shimadzu Sci-
entific Instruments, Columbia, MD). The OneArrayTM Whole 
Genome DNA microarray (Phalanx Biotech, Palo Alto, CA) 
was used for comparing gene expression profiles between cells 
treated with cytokines and control without cytokines. Labeling 
of cDNA, hybridization of labeled cDNA to genome probes, 
and scanning were performed according to the manufacturer’s 
instructions. Every array was performed in triplicate. Data are 
presented as a fold change compared with control.
nF-κB gene silencing
Cells were transfected with siRNA targeting NF-κB p65 or 
a nontargeting control siRNA (final concentration of siRNA 
was 50 nM) in OptiMEM I (Invitrogen, Carlsbad, CA) using 
Lipofectamine 2000 (Invitrogen) (day 0). After 8 hours, 
media were changed to complete medium. On day 2, cells 
were treated with cytokines for an additional 2 to 4 days as 
indicated.
collagen gel contraction assay
Collagen gel contraction assay was performed by a 
modification of a previously published method.3 Briefly, 
native type I collagen gels were prepared by mixing a solution 
of rat tail tendon collagen (approximately 3 mg/mL), EGM-2 
or DMEM (for HPAEC or HFL-1, respectively) and cell 
suspension so that the final mixture resulted in 0.75 mg/mL 
collagen and 3 × 105 cells/mL. A 500 µL aliquot of the 
resulting solution was then cast into each well of a 24-well Journal of Inflammation Research 2011:4 submit your manuscript | www.dovepress.com
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culture plate and allowed to polymerize. After gelation was 
completed, in about 20 minutes at room temperature, the 
gels were gently released into 60-mm dishes (3 gels in each 
dish) containing 5 mL of 1:1 EBM or serum-free DMEM (for 
HPAEC or HFL-1, respectively) with or without cytokines 
and incubated at 37°C for 4 days. Gel size was measured with 
the Optomax V image analyzer (Optomax, Burlington, MA). 
Data are expressed as the percentage of gel area compared 
with the original gel size.
Wound closure assay
Cells were pretreated with or without cytokines (2 ng/mL) in 
a 1:1 EBM for 2 days. Fixed widths of linear wounds were 
then created using a cell scraper (Corning Inc., Corning, 
NY), and the remaining cells were incubated in a 1:4 mixture 
EGM-2 to EBM-2 for 16 hours in the presence or absence 
of cytokines (2 ng/mL). Cells were then fixed, stained, and 
photographed. To quantify cell migration, a grid was lined on 
each image at 0 and 16 hours after wounding by Photoshop 
Elements 2.0 software (Adobe Systems Inc., San Jose, CA) 
to make 1064 tiny squares. The number of squares with 
migrated cells was counted. Three fields for each condition 
were quantified. Data are presented as percentage of squares 
occupied by migrated cells after wounding.
Profiling of Dna content  
by flow cytometry
Nearly confluent cells were treated with or without cytokines 
(2 ng/mL) in EBM-2 only (serum- and growth factor-free 
medium) for 2 days. Both attached and floating cells were 
collected and fixed with cold 70% ethanol in PBS at 4°C for 
30 minutes. Cells were then pelleted by centrifugation and 
resuspended in the staining solution (50 µg propidium iodide, 
100 µg RNase A in 1 mL PBS). After 1 hour staining at 4°C, 
flow cytometric DNA content profiling was performed as 
previously described.3
statistical analysis
Data are expressed as mean ± standard deviation (SD). 
An unpaired 2-tailed Student’s t-test was used for single 
comparisons. P values ,0.05 were considered as statisti-
cally significant.
Results
effect of cytokines on cell morphology 
and endothelial/mesenchymal cell markers
Under control conditions, HPAECs grow as a monolayer 
of polygonal shaped cells. In response to IL-1β or TNF-α, 
HPAECs undergo morphologic alteration. Typically, the 
cells became elongated and spindle shaped and appeared as 
fibroblast-like cells (Figure 1A). The elongation of the cells 
was statistically significant (Figure 1B, P , 0.05). The com-
bination of IL-1β and TNF-α together resulted in a greater 
alteration in cell morphology, which was readily observed 
morphologically (Figure 1A) and confirmed by measurement 
of cell length (Figure 1B, P , 0.05 compared with either 
IL-1β or TNF-α alone). TGF-β1 (2 ng/mL) changed cell 
morphology and cell length in A549 alveolar epithelial cells 
(Figures 1A and B) as reported previously.11,12 In contrast, 
HPAEC morphology was not altered by TGF-β1 at the con-
centration used for A549 cells (2 ng/mL, Figures 1A and B). 
Furthermore, even a higher concentration of TGF-β1 (20 ng/
mL) did not affect HPAEC morphology, and TGF-β1 did not 
affect the HPAEC morphologic change induced by IL-1β or 
TNF-α (data not shown). Consistent with the morphologic 
change, either IL-1β or TNF-α, but not TGF-β1, induced 
F-actin polymerization as visualized by phalloidin binding 
histochemistry (Figure 1C). A similar effect of IL-1β and 
TNF-α on alteration of cell morphology was observed in 
human umbilical vein endothelial cells (HUVEC) obtained 
from Clonetics (data not shown).
To investigate the reversibility of the spindle-shaped 
HPAEC morphology, following a 2-day treatment with 
IL-1β or TNF-α that induced morphologic change, the cells 
were incubated in EGM-2 without cytokines. As a result, 
spindle-shaped cell morphology was reverted to polygonal 
shape completely within 4 days after removal of cytokines 
(data not shown).
We next explored if cytokines affect expression of 
endothelial and mesenchymal markers. Unexpectedly, none 
of the cytokines tested in the current study affected the 
  expression of VE- and N-cadherins, vimentin, or α-smooth 
muscle actin by immunoblot (data not shown). To further 
investigate a wider range of endothelial and mesenchymal 
cell   markers, we performed DNA microarrays (Table 1). 
Using this method, e-selectin gene was observed to be greatly 
increased by IL-1β (8.25-fold) as previously   reported.13 
However, other endothelial cell and adhesion markers were 
unchanged despite the fibroblast-like   morphologic appearance 
induced by IL-1β or TNF-α. Similarly,   mesenchymal 
  markers were not increased by these cytokines except for a 
slight increase in fibronectin 1 (1.88-fold by IL-1β).
To investigate the effect of longer exposure to cytok-
ines, we treated the cells with IL-1β or TNF-α up to 
14 days. Interestingly, cell morphologic change was not 
enhanced by more than 2 days of treatment. In addition, Journal of Inflammation Research 2011:4 submit your manuscript | www.dovepress.com
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endothelial and mesenchymal markers including VE- and 
N-cadherins and vimentin were still not affected (data not 
shown).
effect of Il-1β and TnF-α on cell survival in 
the absence of serum and growth factors
HPAECs were cultured to subconfluence in EGM-2 
(Figure 2A, before treatment panel). When the cells were 
subsequently cultured in EBM-2 without serum and growth 
factors without the addition of cytokines, the majority of 
the cells detached and underwent apoptosis within 5 days 
(Figure 2A, Control panel). In the presence of IL-1β or 
TNF-α, but not in the presence of TGF-β1, however, most of 
the cells remained alive and underwent morphologic change 
in EBM-2 (Figure 2A). Interestingly, the few cells that 
  survived in control conditions or in the presence of TGF-β1 
also had an elongated fibroblast-like appearance.
To evaluate if the detached cells were undergoing 
apoptosis, DNA content was profiled by a FACS analysis 
using propidium iodide staining (Figure 2B). Consistent with 
the microscopic observations, an average of 31.0% ± 4.7% of 
the cells underwent apoptosis after 2 days in the basal medium 
without cytokines (Figure 2B, insert). In   contrast, apoptosis 
was significantly reduced by either IL-1β (8.0% ± 4.2%, 
P , 0.01) or TNF-α (5.2% ± 1.6%, P , 0.01), but not by 
TGF-β1 (32.9% ± 3.3%, P . 0.05).
effect of Il-1β and TnF-α on tissue 
repair functions of hPaecs
To investigate if the inflammatory cytokines could affect 
HPAEC tissue repair functions, wound closure and   collagen 
gel contraction assays were performed. Either IL-1β or 
TNF-α alone stimulated cell migration in the wound closure 
assay (Figures 3A and B). Wound closure (33.3 ± 6.4% in 
Control Control IL-1β
IL-1β + TNF-α TNF-α TGF-β1T GF-β1
A549 HPAEC A
Figure 1 effect of Il-1β, TnF-α and TgF-β1 on cell morphology, actin cytoskeletal arrangement. hPaecs and a549 alveolar epithelial cells were treated with 2 ng/ml of 
Il-1β, TnF-α, or TgF-β1 alone or in combination for 2 days. A) cell morphology. Photographs were taken after Diff Quick staining (original magnification ×400). B) cell 
size. Values are means ± sD of 3 separate experiments. C) actin microfilament polymerization. F-actin was visualized by FITc-phalloidin (original magnification ×600).
Notes: *P , 0.05 compared with control; **P , 0.05 compared with cells treated with Il-1β.
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control) was increased to 71.6% ± 11.9% or 83.8% ± 12.2% 
by IL-1β or TNF-α, respectively (P , 0.05, Figure 3B). The 
two in combination did not further enhance cell migration 
compared with either cytokine alone. In contrast, TGF-β1 
did not affect cell migration.
Collagen gel contraction assay was performed to assess 
the ability of cells to remodel extracellular matrix. Under 
control conditions, normal HPAECs were able to contract 
native type I collagen gels when the cells were cast into the 
gels. Gel size decreased gradually and reached 69.9% ± 8.1% 
of initial size on day 4 (Figure 3C). Gel contraction was sig-
nificantly augmented to 50.8% ± 8.1% and 47.7% ± 12.5% 
of initial size on day 4 by IL-1β or TNF-α, respectively 
(P , 0.05). In contrast, TGF-β1 did not affect gel contrac-
tion (71.9% ± 7.7%, P . 0.05), although TGF-β1 augmented 
human lung fibroblast-mediated collagen gel contraction 
(Figure 3C), which is a well known effect of TGF-β1.3
Role of nF-κB signaling pathway  
in mediating Il-1β or TnF-α effects
To investigate the role of NF-κB in mediating the effects of 
IL-1β or TNF-α on HPAEC, we used both a pharmacologic 
inhibitor and an RNA interference strategy.
Pharmacologic inhibition
Curcumin, an inhibitor of NF-κB signaling, significantly 
blocked not only the cell morphologic change induced by 
IL-1β or TNF-α (Figures 4A and B), but also the increased 
Table 1 gene expression of endothelial and mesenchymal markers
IL-1β TNF-α TGF-β1
endothelial/cell junctional markers
  Ve-cadherin 0.86 0.97 1.02
  TIe1 0.71 0.81 0.83
  TIe2 1.21 0.96 1.02
  VegFR-1 0.97 0.60 0.88
  VegFR-2 (Flk-1) 1.12 1.03 0.99
  PecaM1 (cD31) 1.06 1.00 1.36
  VWF 0.75 0.83 1.27
  e-selectin 8.25 1.58 0.75
  claudin-5 0.96 1.25 0.81
 β -catenin 0.76 0.74 0.86
  ZO-1 0.71 0.76 0.85
Mesenchymal markers
  Vimentin 0.75 0.85 1.16
 α -sMa 1.41 0.87 1.11
  n-cadherin 0.86 0.98 0.69
  collagen I 0.94 1.06 0.91
  Fibronectin 1 1.88 1.25 0.99
Notes: Values are expressed as fold change compared to control; some genes 
which expressions are very low in all conditions are not shown, including collagen III 
and fibroblast specific protein-1.
cell survival observed in the presence of IL-1β or TNF-α 
(Figure 4C).
Rna interference
Introduction of an siRNA targeting p65 into HPAECs 
resulted in remarkable suppression of p65 protein level 
assessed by immunoblot (data not shown). Similar to the 
curcumin effect, suppression of p65 by siRNA not only 
prevented cell morphologic change in response to IL-1β 
and TNF-α   ( Figures 5A and B), but also blocked the 
inhibition of apoptosis by IL-1β or TNF-α (Figure 5C). 
F-actin polymerization induced by IL-1β or TNF-α was 
also abolished by p65-siRNA (Figure 6A). In addition, cells 
lacking p65 were able to migrate and contract collagen 
gels under control conditions, but could not respond to the 
stimulation of IL-1β or TNF-α, while cells transfected with 
the nontargeting control siRNA responded to either cytokine   
significantly (Figures 6B–D).
Discussion
The present study demonstrates that the inflammatory 
cytokines IL-1β and TNF-α induce HPAEC morphologic 
change which resembles that of fibroblasts and render 
the cells resistant to apoptosis following growth factor 
  withdrawal. In addition, IL-1β and TNF-α stimulated 
HPAEC migration and augmented collagen gel contraction 
by HPAEC through the NF-κB signaling.
There is emerging evidence supporting the concept that 
endothelial cells undergo mesenchymal transition, that is, 
endothelial–mesenchymal transition (EndMT). Through 
this mechanism, endothelial cells have been suggested to 
play a role in normal development and may contribute to 
tissue fibrosis.2,14–16 EndMT is generally associated with 
the acquisition of a fibroblast-like morphologic shape, loss 
of endothelial/cell adhesion markers and acquisition of 
mesenchymal markers.14,15 In this regard, the current study 
demonstrated that IL-1β and TNF-α induced fibroblast-
like morphologic change in both HPAEC and HUVEC. 
Interestingly, however, most of the endothelial and mesen-
chymal cell markers were unchanged by these cytokines. 
Although EndMT without a decrease of VE-cadherin has 
been reported by others,17 findings of the current study do 
not meet the criteria for EndMT. However, cells that had 
undergone   morphologic change in response to IL-1β or 
TNF-α became more contractile and migratory. Furthermore, 
IL-1β and TNF-α rendered the HPAECs resistant to 
apoptosis in a growth factor-deficient environment. These 
results   suggest that 1) endothelial cells can contribute to Journal of Inflammation Research 2011:4 submit your manuscript | www.dovepress.com
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tissue repair/remodeling without undergoing “EndMT”, 
2) inflammatory cytokine induced tissue repair may include 
modulating endothelial cell viability, migration and remodel-
ing of extracellular matrix, and 3) acquired apoptosis-resistant 
phenotype may be a mechanism by which endothelial cells 
can survive in an injured area to contribute to tissue repair/
remodeling.
TGF-β1 has been reported to be a major inducer of 
epithelial–mesenchymal transition (EMT) in a variety of 
epithelial cells.11,12,18 TGF-β1 can also induce EndMT in 
certain endothelial cells.14,17 In the present study, however, 
TGF-β1 did not affect HPAEC morphology, migration, 
or contractility of collagen gels. This phenomenon is 
unlikely due to lack of activity of TGF-β1 in that the same 
concentration of  TGF-β1 could induce EMT in A549 cells and 
augment collagen gel contraction by lung fibroblasts, which 
were reported previously.3,11,12 Multiple mechanisms may 
be account for the different effect of TGF-β1 in endothelial 
cells. First, it might be due to relatively lower expression of 
TGF-β receptors in HPAEC as evidenced by immunoblot 
(data not shown). Second, expression of endogenous inhibi-
tors of Smad pathway signaling, for instance, Smad 7, could 
render cells resistant to TGF-β1. Third, endothelial cells may 
lack required cofactors. In this regard, Hashimoto et al have 
recently reported that combined treatment of Ras and TGF-β 
could induce EndMT in pulmonary microvascular endothelial 
cells,16 suggesting some cofactors may be required for TGF-
β-induced EndMT in certain endothelial cells.
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Figure 2 effect of cytokines on cell survival following withdrawal of growth factors. The subconfluent cells (before treatment, upper left panel) were cultured in serum and 
growth factor-free medium with or without 2 ng/ml of cytokines. A) Microscopic observation after 5 days of treatment. The cells remaining attached to the culture dish were 
fixed, stained, and photographed (original magnification ×200). B) Profiling of Dna contents after 2 days of treatment. Both floating and attached cells were collected and Dna 
content was profiled by Facs analysis. Facs tracings are from a single experiment. Insert: Percentage of apoptotic cells. Values are means ± sD of 3 separate experiments. 
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In the current study, we demonstrated the involvement of 
the NF-κB signaling pathway in cellular responses induced 
by IL-1β or TNF-α. Consistent with previous reports,1,8,9 
IL-1β and TNF-α activated NF-κB signaling as evidenced 
by induction of phosphorylated-p65 (data not shown). 
More importantly, siRNA targeting p65 blocked the effect 
of morphologic alteration, cell survival, cell migration, and 
contraction of collagen gels induced by IL-1β- and TNF-α. 
These findings suggest that NF-κB p65 activation in response 
to IL-1β or TNF-α is essential for HPAEC functions related 
to tissue repair/remodeling.
Besides lack of change in endothelial and mesenchymal 
cell markers in HPAECs treated with IL-1β or TNF-α, there 
are several differences between fibroblast-like spindle-shaped 
HPAECs and “real” lung fibroblasts directly derived from 
embryonic mesenchymal cells. First, fibroblasts grow well 
in 10% FBS-DMEM, while fibroblast-like spindle-shaped 
HPAECs were not able to survive in this medium (data 
not shown). Second, following removal of the cytokines, 
fibroblast-like HPAEC morphology reverted to the polygonal 
endothelial morphology. Even if HPAECs were exposed to 
the cytokines in the longer term (up to 14 days), none of 
these fibroblast phenotypes were induced except for spindle-
shaped morphology. Incomplete fibroblast-like functions and 
reversible phenotypic alteration in endothelial cells might be 
important for angiogenesis.
Apoptosis, programmed cell death, is a major mechanism 
by which cells are removed from tissues. Apoptosis can be 
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Figure 3 effect of cytokines on wound closure and gel contraction. A) Microscopic observation of wound closure assay. cells were treated with 2 ng/ml of cytokines for 
2 days. after wounding, cells were incubated for 16 hours followed by microphotography as shown (original magnification ×40). B) Quantification of wound closure assay. 
cell migration was quantified by counting migrated area at 0 and 16 hours after wounding. Data presented are means ± sD of 3 separate experiments. C) gel contraction 
assay. hPaecs and human fetal lung fibroblasts (hFl-1) were cast into collagen gels (day 0) and treated with or without 2 ng/ml of cytokines for 4 days. Vertical axis: gel 
size expressed as percent of initial size (%). Data presented are means ± sD of 3 separate experiments. 
Notes: *P , 0.05 compared with control; **P , 0.01 compared with control.Journal of Inflammation Research 2011:4 submit your manuscript | www.dovepress.com
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Figure 4 effect of nF-κB inhibitor on cell morphology and cell survival. A) cell morphology. cells were cultured in presence or absence of curcumin (10 µM) for 2 days 
(original magnification ×400). B) cell length. Values are means ± sD of 3 separate experiments. C) cell survival. subconfluent cells were cultured with or without curcumin 
in serum and growth factors free medium for 5 days.
Notes: *P , 0.05 compared with control; **P , 0.05 compared with cells treated with Il-1β; +P , 0.05 compared to same cytokine treatment without curcumin.
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Figure 5 effect of suppression of nF-κB p65 by siRna on cell morphology and cell survival. A) cell morphology. after Rna interference, cells were treated with 2 ng/ml 
cytokines for 2 days (original magnification ×400). B) cell length. Values are means ± sD of 3 separate experiments. C) cell survival. after Rna interference, cells were 
treated with 2 ng/ml cytokines in serum and growth factor-free medium for 4 days (original magnification ×200).
Notes: *P , 0.05 compared with control; **P , 0.05 compared with cells treated with Il-1β; +P , 0.05 compared with same cytokine treatment transfected with nontargeting siRna.
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triggered by a variety of stimuli including inflammatory 
cytokines. In this regard, both IL-1β and TNF-α are known 
to induce apoptosis in several cell types including airway 
epithelial cells and fibroblasts and microvascular endothelial 
cells.19–21 In contrast to these reports, here we report that IL-1β 
and TNF-α not only protected HPAECs from undergoing 
apoptosis in response to withdrawal of growth factors and 
serum, but also induced HAPECs to undergo morphologic 
alteration. This suggests that cells undergoing fibroblast-like 
morphologic change may activate a mechanism by which 
cells can survive in an injured area and may contribute to 
tissue repair or fibrosis. This also suggests that pulmonary 
artery endothelial cells may be involved in the pathogenesis 
of respiratory diseases such as pulmonary hypertension 
and fibrosis through a mechanism of extended survival and 
fibroblast-like alteration following airway inflammation. 
Therefore, pulmonary endothelial cells might also be a thera-
peutic target for diseases including pulmonary hypertension 
and lung fibrosis.
Conclusion
IL-1β and TNF-α, but not TGF-β1, induce HPAEC to 
undergo morphologic alteration from a polygonal shape to 
spindle-shaped fibroblast-like cells. IL-1β and TNF-α, but 
not TGF-β1, prevent cells from apoptosis induced by the 
absence of serum and growth factors, stimulate migration, 
and augment contraction of collagen gels. The NF-κB signal-
ing pathway mediates all these effects of IL-1β and TNF-α 
on HPAEC. These findings suggest that endothelial cells, 
in response to inflammatory cytokines, may contribute to 
tissue repair/remodeling and, possibly, to pathologic tissue 
alterations.
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